NICM
KDNY

Neo Ivy Capital Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Neo Ivy Capital Management’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-18,648
Closed -$716K – 488
2023
Q2 		$716K Buy
+18,648
New +$479K 0.38% 97

Neo Ivy Capital Management's KDNY Position: Q3 2023 in Review

Neo Ivy Capital Management sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 18,648 shares — an estimated $716K sold.

Neo Ivy Capital Management first reported a position in KDNY in Q2 2023 and held it in 1 quarter. The position peaked at $716K in Q2 2023. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.

  • Neo Ivy Capital Management reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Neo Ivy Capital Management sold 18,648 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $716K.
  • Neo Ivy Capital Management first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
  • Neo Ivy Capital Management's Chinook Therapeutics, Inc. Common Stock position peaked at $716K in Q2 2023.
  • 2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Neo Ivy Capital Management's 13F filing for Q3 2023, filed 30 Nov 2023.